WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008094678) A MOLECULAR PROGNOSTIC SIGNATURE FOR PREDICTING BREAST CANCER DISTANT METASTASIS, AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/094678    International Application No.:    PCT/US2008/001339
Publication Date: 07.08.2008 International Filing Date: 31.01.2008
IPC:
C12Q 1/68 (2006.01), C07H 21/04 (2006.01), G01N 33/53 (2006.01), G01N 33/536 (2006.01), G01N 33/543 (2006.01)
Applicants: APPLERA CORPORATION [US/US]; Celera, An Applera Business Unit, 1401 Harbor Bay Parkway, Alameda, California 94502 (US) (For All Designated States Except US).
LAU, Kit [CA/US]; (US) (For US Only).
WANG, Alice [US/US]; (US) (For US Only)
Inventors: LAU, Kit; (US).
WANG, Alice; (US)
Agent: LEE, Victor; Celera, An Applera Business Unit, 1401 Harbor Bay Parkway, Alameda, California 94502 (US)
Priority Data:
60/898,963 31.01.2007 US
Title (EN) A MOLECULAR PROGNOSTIC SIGNATURE FOR PREDICTING BREAST CANCER DISTANT METASTASIS, AND USES THEREOF
(FR) SIGNATURE PRONOSTIQUE MOLÉCULAIRE POUR PRÉDIRE DES MÉTASTASES DISTANTES CHEZ LES FEMMES ATTEINTES D'UN CANCER DU SEIN, ET SES UTILISATIONS
Abstract: front page image
(EN)The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
(FR)Cette invention se rapporte à la découverte d'une signature pronostique moléculaire unique de 14 gènes utilisée pour prédire un cancer du sein métastatique. L'invention concerne en particulier des procédés et des réactifs permettant de détecter et de suivre les taux d'expression de ces gènes, ainsi que des procédés permettant d'utiliser les données concernant ces taux d'expression pour prédire le risque d'un cancer du sein métastatique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)